Fresenius Kabi
News
May 27, 2020
FDA Accepts for Review Fresenius Kabi’s BLA Submission for Pegfilgrastim Biosimilar
read moreMay 12, 2020
Fresenius Kabi Adds Micafungin for Injection to Expanding Anti-Infective Portfolio
read moreMay 7, 2020
Fresenius Kabi Announces Availability of Potassium Phosphates Injection, USP in Three Presentations
read moreApril 20, 2020
Fresenius Kabi Issues Voluntary Nationwide Recall of 13 Lots of Ketorolac Tromethamine Injection, USP Due to the Presence of Particulate Matter in Reserve Samples
read moreApril 7, 2020
TO HONOR AMERICA’S NURSES ON THE FRONT LINES OF THE COVID-19 RESPONSE, KINO LORBER LAUNCHES FREE STREAMING OF ACCLAIMED DOCUMENTARY ‘THE AMERICAN NURSE’
read moreFebruary 5, 2020
Fresenius Kabi Introduces Glucagon Emergency Medicine Kit to Treat Life-Threatening Episodes of Low Blood Sugar
read moreJanuary 29, 2020
CMS Assigns HCPCS Level II Code for Omegaven® (fish oil triglycerides) from Fresenius Kabi
read moreJanuary 21, 2020
Three Industry Leaders Form New Venture to Create Scalable Manufacturing Platforms for Cell and Gene Therapies
read moreDecember 19, 2019
Fresenius Kabi Announces Availability of Dicyclomine Hydrochloride Injection, USP 20 mg Vial
read moreDecember 11, 2019
Fresenius Kabi Expands Anti-Infective Portfolio with Launch of Ertapenem for Injection in 1 Gram Vial Presentation
read more
- October 2 - 7, 2020
- |
- Washington, D.C.
